U.S. Tobacco Stock News

Monte Rosa Therapeutics (GLUE) just posted its FY 2025 third quarter numbers, with revenue of US$12.8 million and a basic EPS loss of US$0.33 off a net income loss of US$27.1 million, setting a clear snapshot of where the business stands today. Over recent periods, the company has seen revenue move from US$60.6 million in Q4 2024 to US$84.9 million in Q1 2025, then to US$23.2 million in Q2 2025 and US$12.8 million in Q3 2025. Over the same timeframe, basic EPS shifted from a profit of US$0.16...

Embassy Bancorp (EMYB) has posted a clean set of Q3 2025 numbers, with total revenue of US$11.7 million and basic EPS of US$0.50, against a 12 month backdrop where revenue on a trailing basis moved from US$39.8 million to US$44.0 million and EPS from US$1.37 to US$1.68. The latest quarter sits within a year where earnings grew 21.3% versus the longer term trend and sets the stage for investors to focus on how a 29.1% net margin and a 2.58% net interest margin shape the quality and resilience...

Kaspi.kz (NasdaqGS:KSPI) has posted its FY 2025 results with Q4 revenue at KZT 1.1t and net income at KZT 276,983 million, translating into basic EPS of KZT 1,451.81, against a backdrop of trailing 12 month revenue of KZT 4.0t and net income of KZT 1,073,177 million. Over recent periods, the company has seen revenue move from KZT 744,178 million in Q4 2024 to KZT 1,146,548 million in Q4 2025, while quarterly basic EPS shifted from KZT 1,641.41 to KZT 1,451.81 and trailing basic EPS moved from...

Black Diamond Therapeutics (BDTX) just posted a sharp swing into profit for FY 2025, with first half revenue of US$70 million translating to basic EPS of US$0.81, compared with losses in both halves of FY 2024. Over the past year, the company has seen revenue move from US$0 to US$70 million while basic EPS has shifted from losses of US$0.71 and US$0.56 in FY 2024 to a trailing 12 month figure of US$0.25. This sets up a results season where investors will focus squarely on how durable these...

Stoke Therapeutics (STOK) has reported FY 2025 results that feature a wide range of quarterly outcomes. Q1 revenue was US$158.6 million with EPS of US$1.95, followed by Q2 revenue of US$13.8 million and an EPS loss of US$0.40, and Q3 revenue of US$10.6 million with an EPS loss of US$0.65. Over recent periods the company has seen revenue move between US$4.8 million and US$158.6 million per quarter, while EPS has shifted from a US$2.07 loss in FY 2024 to a US$1.95 profit and then back into...

WW International (WW) has just posted its FY 2025 results with Q3 revenue of US$172.1 million and a basic EPS loss of US$1.04, set against a trailing 12 month net income of about US$1.1 billion that reflects a large one off gain. Over recent quarters the company has seen revenue move between US$184.4 million and US$202.1 million, while EPS has swung from a profit of US$0.31 to a loss of US$0.91 and then a very large profit of US$15.71. This pattern points to margins that appear to be heavily...

Earlier this week, Savers Value Village reported preliminary fourth-quarter results showing an 8.8% rise in U.S. comparable sales and 0.7% growth in Canada, while President and COO Jubran N. Tanious exercised options for 100,000 shares at US$1.41 and sold 45,000 shares for about US$373,644 on March 11, 2026. This combination of stronger U.S. store performance and fresh insider share activity offers investors new information on both operational momentum and executive incentives. We’ll now...

Q3 2026 snapshot: Value Line (VALU) leans on margins as earnings trends soften Value Line (VALU) has just reported its Q3 2026 results, with recent quarters showing revenue around US$8.6 million and basic EPS between US$0.42 and US$0.69, while trailing twelve month EPS sits a little above US$2.25. Over the last six reported quarters, revenue has ranged from US$8.39 million to US$8.97 million and basic EPS has moved between US$0.42 and US$0.69, setting up a picture where high profitability...

Coya Therapeutics (COYA) has released its FY 2025 results, reporting fourth quarter revenue of US$4.0 million and a basic EPS loss of US$0.34, alongside trailing twelve month revenue of US$7.9 million and a basic EPS loss of US$1.27. The company’s revenue increased from US$0.00 million in the third quarter of 2024 to US$3.6 million in the third quarter of 2025, while quarterly basic EPS has ranged from a loss of US$0.44 in the first quarter of 2025 to a loss of US$0.13 in the third quarter of...

Zomedica (OTCPK:ZOMD.F) has reported its FY 2025 third quarter with total revenue of US$8.1 million and a basic EPS loss of US$0.006, alongside a net loss of US$6.1 million. Over recent quarters, revenue has moved from US$6.1 million in Q2 2024 to US$6.5 million in Q1 2025 and US$8.1 million in Q3 2025, while quarterly net losses have ranged from US$6.1 million to US$63.8 million and trailing twelve month revenue has reached US$29.5 million against a trailing net loss of US$84.5 million. For...

Consolidated Water (CWCO) has put up another solid top line in FY 2025 so far, with Q3 revenue of about US$35.1 million and basic EPS of roughly US$0.35, while the latest trailing twelve months show revenue of about US$130.8 million and EPS of around US$1.09. Over recent periods the company has seen revenue move from roughly US$28.4 million in Q4 2024 to US$35.1 million in Q3 2025, with quarterly EPS shifting from about US$0.11 to US$0.35 over the same stretch. This sets up a story where...

The FDA approved an updated label for Krystal Biotech's Vyjuvek (beremagene geperpavec svdt) for epidermolysis bullosa. KB803 progressed as an emerging therapy candidate in Krystal Biotech's pipeline. These developments affect the treatment options available for epidermolysis bullosa and the outlook for NasdaqGS:KRYS. Krystal Biotech, listed on NasdaqGS:KRYS, focuses on gene therapies for rare skin conditions such as epidermolysis bullosa. With Vyjuvek already in the market and KB803 moving...

Bumble (BMBL) has wrapped up FY 2025 with fourth quarter revenue of US$224.2 million and a basic EPS loss of US$4.06, alongside a net income loss of US$499.4 million. Over recent periods the company has seen quarterly revenue move from US$261.6 million in Q4 2024 to US$247.1 million in Q1 2025, US$248.2 million in Q2, US$246.2 million in Q3, and US$224.2 million in Q4. EPS swung between a profit of US$0.34 in Q3 and losses such as US$2.45 in Q2 and US$4.06 in Q4, setting up a story that is as...

Summit Midstream (SMC) has reported third quarter FY 2025 revenue of US$138.0 million with a basic EPS loss of US$0.13, as continued losses keep profitability in focus for investors. The company has seen revenue move from US$93.2 million in Q2 FY 2024 to US$138.0 million in Q3 FY 2025, while basic EPS over the same stretch has ranged from a loss of US$19.25 per share in Q3 FY 2024 to a loss of US$0.13 per share in the latest quarter, keeping margins firmly in the red and the quality of the...

Latest FY 2025 earnings snapshot Security National Financial (SNFC.A) closed FY 2025 with fourth quarter revenue of US$83.0 million and basic EPS of US$0.55, alongside trailing 12 month figures of US$344.6 million in revenue and EPS of US$1.30 that sit against earnings growth of 21.2% over the past year. Over recent periods, revenue has moved from US$79.3 million and EPS of effectively zero in Q4 2024 to US$83.0 million and EPS of US$0.55 in Q4 2025. Trailing net income reached US$32.2...

Citi Trends (CTRN) has reported another mixed set of numbers for FY 2026, with third quarter revenue of US$197.1 million, an EPS loss of US$0.86, and a net income loss of US$6.9 million, alongside same store sales growth of 10.8%. Over recent quarters, revenue has moved from US$176.6 million and an EPS loss of US$2.21 in Q2 2025, to US$179.1 million and an EPS loss of US$0.86 in Q3 2025, then to US$201.7 million with EPS of US$0.11 in Q1 2026 and US$190.8 million with EPS of US$0.48 in Q2...

Silvercrest Asset Management Group (SAMG) has reported third quarter FY 2025 revenue of US$31.3 million and basic EPS of US$0.07, with trailing 12 month revenue at US$125.3 million and EPS at US$0.73 providing the broader earnings backdrop. Over recent periods, revenue has moved between US$30.4 million and US$31.4 million per quarter, while quarterly EPS has ranged from US$0.07 to US$0.28. This gives investors a clearer view of how the income statement has evolved into the current trailing 12...

Natural Gas Services Group's FY 2025 Earnings Snapshot Natural Gas Services Group (NGS) has reported its FY 2025 results with third quarter revenue of US$43.4 million and basic EPS of US$0.46, alongside trailing twelve month revenue of US$166.8 million and EPS of US$1.49 that frame the scale of the current earnings run rate. Over recent periods the company has seen revenue move from US$38.5 million in Q2 2024 to US$43.4 million in Q3 2025, while quarterly EPS has ranged from US$0.23 in Q4...

Orange County Bancorp (OBT) has just wrapped up FY 2025 with fourth quarter total revenue of US$31.5 million, basic EPS of US$0.93 and net income of US$12.4 million. This sets the tone for how investors will read the full year against recent momentum in the share price around US$31.40. The company has seen revenue move from US$27.4 million and EPS of US$0.63 in Q4 2024 to US$31.5 million and EPS of US$0.93 in Q4 2025. Trailing twelve month figures sit at US$119.5 million of revenue and EPS of...

Latest FY 2025 Results Set the Tone for BingEx (FLX) BingEx (FLX) has put fresh FY 2025 numbers on the table, with Q3 revenue of C¥1,005.4 million and basic EPS of C¥0.63 framing a quarter that sits between a weak start to the year and a stronger Q2 print. The company has seen quarterly revenue move from C¥960.8 million in Q1 2025 to C¥1,024.6 million in Q2 and then C¥1,005.4 million in Q3, while basic EPS has swung from a loss of C¥0.15 in Q1 to C¥0.77 in Q2 and C¥0.63 in Q3. This gives...

Playboy (PLBY) has just posted a small profit for Q3 2025, with revenue of US$29.0 million and net income of US$0.46 million translating to basic EPS of US$0.00 when rounded, a marked contrast to prior quarterly losses. Over recent periods the company has seen quarterly revenue move in a tight band around the high US$20 million level, with basic EPS running from a loss of US$0.45 in Q3 2024 to a loss of US$0.10 in Q1 2025 before this latest positive print. This sets up a results season where...

Getty Images Holdings (GETY) has just closed out FY 2025 with fourth quarter revenue of US$282.3 million and a basic EPS loss of US$0.22, alongside trailing twelve month revenue of US$981.3 million and a trailing EPS loss of US$0.50. Over the past year, the company has seen quarterly revenue range from US$224.1 million to US$282.3 million, with EPS swinging between a profit of US$0.05 in Q3 2025 and losses of up to US$0.25 in Q1 2025. During the same period, trailing net income moved from a...

Primis Financial's FY 2025 Earnings Snapshot Primis Financial (FRST) closed FY 2025 with fourth quarter revenue of US$78.4 million and basic EPS of US$1.20, while trailing twelve month revenue reached US$211.3 million and EPS came in at US$2.49. Over recent periods, revenue has moved from US$5.8 million in Q4 2024 to US$78.4 million in Q4 2025, and basic EPS has shifted from a loss of US$0.94 per share in Q4 2024 to EPS of US$1.20, putting margins and profitability under closer scrutiny for...

Bicycle Therapeutics (BCYC) has just posted its FY 2025 third quarter numbers, with revenue of about US$11.7 million and a basic EPS loss of US$0.85. Trailing twelve month figures show revenue of roughly US$28.3 million and a basic EPS loss of US$3.62. Over recent quarters, revenue has ranged from US$2.9 million to US$11.7 million, while quarterly basic EPS losses have moved between US$0.74 and US$1.14. This gives investors a clearer sense of a business that appears to be in investment mode...